| |
| Please Note - Streaming News is only available to subscribers to the Active Level and above |
|
|
|
RNS News Service
I confirm that I am accessing this story in my capacity as a private investor and NOT for professional purposes.
Willis Towers Watson plc 8.3
RNS
|
RNS Number : 9507C
J.P. Morgan Securities LLC
22 October 2020
Ap19
FORM
8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1.
KEY
INFORMATION
|
Nameofpersondealing
(Note
1)
|
J.P. Morgan Securities LLC
|
|
Companydealtin
|
Willis Towers Watson plc
|
|
Classofrelevantsecuritytowhichthe dealingsbeingdisclosedrelate
(Note
2)
|
US$0.000304635 ordinary shares
|
|
Date
of
dealing
|
21 October 2020
|
2.
INTERESTS AND SHORT POSITIONS
(a)
Interests
and
short
positions
(following
dealing)
in
the
class
of
relevant
security
dealt
in
(Note
3)
|
|
Long
|
Short
|
|
|
Number
|
|
(%)
|
Number
|
|
(%)
|
|
(1)Relevantsecurities
|
2,519,978 1.96
|
2,302,572 1.79
|
|
(2)
Derivatives
(other
than
options)
|
2,310,788 1.79
|
2,239,345 1.74
|
|
(3)Optionsandagreementstopurchase/sell
|
|
|
|
Total
|
4,830,766 3.75
|
4,541,917 3.53
|
| |
|
|
|
|
|
|
Ap20
1.
DEALINGS
(Note
4)
(a) Purchases and sales
|
Purchase/sale
|
Numberofrelevantsecurities
|
Priceperunit(USD)
(Note
5)
|
|
Sale (Borrow Return)
Purchase
Sale
|
39,500
106
4,457
187
300
100
240
300
100
187
100
100
100
200
100
150
300
1
100
300
180
68
1
47
6,978
100
100
90
100
100
35
316
100
100
101
100
118
15
105
100
5
1,200
6,878
100
100
100
100
100
100
20
100
100
100
100
300
52
100
100
200
31
100
100
113
100
100
3,616
100
200
100
100
200
100
100
100
106
22,017
264
300
800
100
480
100
300
6
100
100
100
100
300
100
250
516
200
1
100
300
105
180
145
547
6,978
100
377
100
300
100
90
100
35
16
120
100
100
308
100
100
118
200
200
100
100
5
1,200
200
101
6,878
100
100
200
100
100
100
10
20
100
200
100
100
104
200
200
400
62
200
200
100
200
200
200
300
200
100
200
300
200
100
100
200
100
|
NA
209.3353
209.3700
209.4000
209.4067
209.4700
209.4975
209.5733
209.7600
209.7768
209.8200
209.8500
209.8800
209.9400
209.9800
210.0000
210.0100
210.0200
210.0300
210.0400
210.0689
210.0690
210.0700
210.1000
210.1200
210.1300
210.1500
210.1568
210.1600
210.1700
210.2000
210.2100
210.2300
210.2600
210.3100
210.3500
210.3900
210.4140
210.4400
210.4600
210.4700
210.4765
210.5183
210.5200
210.5400
210.5700
210.6100
210.6400
210.6500
210.7200
210.7500
210.7600
210.8000
210.8100
210.9267
210.9400
211.0800
211.1800
211.1950
211.2600
211.2900
211.4100
211.5264
211.5500
211.5600
211.6700
211.7500
211.9050
211.9100
211.9300
212.4150
212.4600
212.7000
212.7400
209.3353
209.3700
209.4000
209.4067
209.4500
209.4700
209.4975
209.5300
209.5733
209.5900
209.7600
209.8200
209.8500
209.8800
209.9400
209.9800
210.0000
210.0065
210.0100
210.0200
210.0300
210.0400
210.0510
210.0689
210.0698
210.1000
210.1200
210.1300
210.1326
210.1400
210.1433
210.1500
210.1568
210.1600
210.2000
210.2100
210.2200
210.2300
210.2600
210.2727
210.3100
210.3500
210.3900
210.4100
210.4250
210.4400
210.4600
210.4700
210.4765
210.4900
210.5151
210.5183
210.5200
210.5400
210.5700
210.6100
210.6400
210.6500
210.6700
210.7200
210.7500
210.7750
210.8000
210.8100
210.9400
211.0800
211.1800
211.1950
211.2600
211.2900
211.4100
211.5500
211.5600
211.6500
211.7500
211.7667
211.9050
211.9100
211.9300
212.3100
212.4150
212.4200
212.4600
212.7000
212.7400
|
(b) Derivatives transactions (other than options transactions)
|
Productname,
e.g.
CFD
|
Natureoftransaction
(Note
6)
|
Numberofrelevantsecurities
(Note
7)
|
Priceperunit
(USD)
(Note
5)
|
|
Equity Swap
|
Long
Short
|
18,200
43
90
1,200
|
209.3700
209.3700
210.1568
210.4765
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
|
Productname,
e.g.
call
option
|
Writing,
selling,purchasing,varyingetc.
|
Numberofsecurities towhichtheoptionrelates
(Note
7)
|
Exercise price
|
Type,
e.g.American,Europeanetc.
|
Expiry date
|
Optionmoney paid/receivedperunit
(Note
5)
|
|
|
|
|
|
|
|
|
(ii) Exercising
|
Productname,
e.g.
call
option
|
Numberofsecurities
|
Exercisepriceper unit
(Note
5)
|
|
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
|
Nature
of
transaction
(Note
8)
|
Details
|
Price
per
unit
(if applicable)
(Note 5)
|
|
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any
relevant securities to which any derivative referred to on this form is referenced. If none, this
should be stated.
None
Is a Supplemental Form 8 attached?
(Note
9)
NO
|
Dateofdisclosure
|
22 October 2020
|
|
Contact
name
|
Alwyn Basch
|
|
Telephone
number
|
0207 742 7407
|
|
If
aconnectedEFM,nameofofferee/offerorwithwhichconnected
|
N/A
|
|
If
aconnectedEFM,statenatureofconnection
(Note
10)
|
N/A
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com. RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END
ISEFLLFLBBLZFBF
|
|
|
|
|
|
